Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various therapeutic agents. Its structure is particularly valuable in developing drugs targeting inflammatory and autoimmune diseases due to its ability to modulate specific biological pathways. Additionally, it is utilized in the creation of small molecule inhibitors that can interfere with protein-protein interactions, making it significant in cancer research. The trifluoromethyl group enhances its metabolic stability and binding affinity, which is crucial for optimizing drug efficacy and pharmacokinetics.